Loading clinical trials...
Loading clinical trials...
The study explores the impact of a digital app for the self-management of (peri-)menopausal disorders. A total of 224 participants were randomized into an intervention and a control group. Findings indicate that the app offers beneficial effects on menopausal symptoms and menopause-specific quality-of-life. The study also provided valuable insights for the design of future larger trials and highlights the promising potential of the app to enhance individualized care.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Endo Health GmbH
Chemnitz, Saxony, Germany
Start Date
August 9, 2024
Primary Completion Date
December 30, 2024
Completion Date
December 30, 2024
Last Updated
May 23, 2025
224
ACTUAL participants
Menopause App
DEVICE
Lead Sponsor
Endo Health GmbH
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions